damage. The study carried out on hydrogel implanted rabbits showed no adverse effects even after
410 days of treatment.
The unique ability of newly developed hydrogel to transform into gel form in very short period and
low polymer concentration makes it suitable for broader applications to treat trauma, tumors, and
vitreoretinal disease. Potential development in vitreous substitutes are further expected to drive
growth of the vitreous tamponades market in near future.
The major players operating in the global vitreous tamponades market includes Alcon, Inc., Carl
Zeiss Meditec AG, Fluoron GmbH, D.O.R.C. Dutch Ophthalmic Research Center B.V.,
AL.CHI.MI.A.SRL, CROMA-PHARMA GmbH, and Valeant Pharmaceuticals International, Inc.
Request For Customization @ https://www.coherentmarketinsights.com/insight/request-
customization/1193
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]